Company Overview
CNS Pharm Korea Co., Ltd., founded in 2022, is an OEM and ODM company which plans, researches, and develops health functional food that satisfy the market, customers, and consumers through the latest equipment and rigorous quality control.
In order to observe the rapidly changing health functional food market and consumers' interest in health from a sensitive and attentive perspective and to produce products that are in line with this, we spare no effort to improve and develop R&D and quality management every year. In addition, all employees are committed to putting quality management at the top of our business capabilities above all other issues, and to develop differentiated capabilities as a company that can be trusted with products that can be consumed with peace of mind.
Through these efforts, we are supplying quality products to leading domestic companies as well as overseas partners and forming trusted partnerships and we have laid the foundation to respond to more diverse formulations and higher production volumes with the expansion of our production headquarters in 2023.
In addition, we have successfully developed and produced LD100®, our own proprietary ingredient subject to individual recognition ingredient and we aim to become a global-level R&D and manufacturing company, not just an OEM/ODM company, by discovering and strengthening a pipeline of various proprietary ingredients.
In order to observe the rapidly changing health functional food market and consumers' interest in health from a sensitive and attentive perspective and to produce products that are in line with this, we spare no effort to improve and develop R&D and quality management every year. In addition, all employees are committed to putting quality management at the top of our business capabilities above all other issues, and to develop differentiated capabilities as a company that can be trusted with products that can be consumed with peace of mind.
Through these efforts, we are supplying quality products to leading domestic companies as well as overseas partners and forming trusted partnerships and we have laid the foundation to respond to more diverse formulations and higher production volumes with the expansion of our production headquarters in 2023.
In addition, we have successfully developed and produced LD100®, our own proprietary ingredient subject to individual recognition ingredient and we aim to become a global-level R&D and manufacturing company, not just an OEM/ODM company, by discovering and strengthening a pipeline of various proprietary ingredients.
